{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:11:30Z","timestamp":1761419490132,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.hlc.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T18:44:18Z","timestamp":1626115458000},"page":"1805-1810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Operator and Institutional Requirements for Transcatheter Mitral Valve Therapies in Australia: a CSANZ and ANZSCTS Position Statement"],"prefix":"10.1016","volume":"30","author":[{"given":"David W.M.","family":"Muller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aubrey","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8435-3986","authenticated-orcid":false,"given":"Anthony","family":"Camuglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurgen","family":"Passage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Scalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinay","family":"Bhindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidney","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayme","family":"Bennetts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.hlc.2021.07.001_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0195-668X(03)00201-X","article-title":"A\u00a0prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease","volume":"24","author":"Iung","year":"2003","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.hlc.2021.07.001_bib2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2217\/cer-2019-0026","article-title":"Twelve-month healthcare utilization and expenditures in Medicare fee-for-service patients with clinically significant mitral regurgitation","volume":"8","author":"Mehta","year":"2019","journal-title":"J\u00a0Comp Eff Res"},{"issue":"9540","key":"10.1016\/j.hlc.2021.07.001_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"issue":"36","key":"10.1016\/j.hlc.2021.07.001_bib4","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hlc.2021.07.001_bib5","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.hlc.2021.07.001_bib6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jacc.2009.03.079","article-title":"Failure of guideline adherence for intervention in patients with severe mitral regurgitation","volume":"54","author":"Bach","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10124","key":"10.1016\/j.hlc.2021.07.001_bib7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0140-6736(18)30473-2","article-title":"Outcome and undertreatment of mitral regurgitation: a community cohort study","volume":"391","author":"Dziadzko","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.hlc.2021.07.001_bib8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/eurheartj\/ehm001","article-title":"What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?","volume":"28","author":"Mirabel","year":"2007","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hlc.2021.07.001_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1312808","article-title":"Mitral-valve repair versus replacement for severe ischemic mitral regurgitation","volume":"370","author":"Acker","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hlc.2021.07.001_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJMoa1512913","article-title":"Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation","volume":"374","author":"Goldstein","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2021.07.001_bib11","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMoa1602003","article-title":"Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation","volume":"374","author":"Michler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2021.07.001_bib12","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2021.07.001_bib13","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hlc.2021.07.001_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jacc.2015.12.054","article-title":"Initial experience with commercial transcatheter mitral valve repair in the United States","volume":"67","author":"Sorajja","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.hlc.2021.07.001_bib17","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jcin.2019.04.034","article-title":"Transcatheter valve repair for patients with mitral regurgitation: 30-day results of the CLASP Study","volume":"12","author":"Lim","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.hlc.2021.07.001_bib18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/eurjhf\/hfs076","article-title":"Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial","volume":"14","author":"Siminiak","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.hlc.2021.07.001_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jacc.2016.10.068","article-title":"Tendyne Global Feasibility Trial Investigators. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: A global feasibility trial","volume":"69","author":"Muller","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2021.07.001_bib20","first-page":"731250","article-title":"Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients","author":"Sorajja","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hlc.2021.07.001_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jacc.2017.10.061","article-title":"Early experience with new transcatheter mitral valve replacement","volume":"71","author":"Bapat","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2021.07.001_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jacc.2019.12.002","volume":"76","author":"Bonow","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.hlc.2021.07.001_bib23","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.jacc.2018.10.007","volume":"73","author":"Nishimura","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.hlc.2021.07.001_bib24","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jamacardio.2020.2221","article-title":"Volume-outcome association of mitral valve surgery in the United States","volume":"5","author":"Badhwar","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hlc.2021.07.001_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2017.02.026","article-title":"Relation of mitral valve surgery volume to repair rate, durability, and survival","author":"Chikwe","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"26","key":"10.1016\/j.hlc.2021.07.001_bib26","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMsa1901109","article-title":"Procedural volume and outcomes for transcatheter aortic-valve replacement","volume":"380","author":"Vemulapalli","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.hlc.2021.07.001_bib27","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jcin.2019.02.039","article-title":"Institutional experience with transcatheter mitral valve repair and clinical outcomes: insights from the TVT Registry","volume":"12","author":"Chhatriwalla","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"10.1016\/j.hlc.2021.07.001_bib28","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jcin.2019.05.008","article-title":"Volume-outcome relationships for transcatheter mitral valve repair: more is better","volume":"12","author":"Stone","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.hlc.2021.07.001_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCULATIONAHA.120.051501","article-title":"Perspective to 2020 AHA\/ACC Guideline for the management of patients with valvular heart disease","volume":"143","author":"Bavry","year":"2020","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.hlc.2021.07.001_bib31","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2018.04.031","article-title":"Transcatheter tricuspid valve interventions: landscape, challenges, and future directions","volume":"71","author":"Asmarats","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950621011161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950621011161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:04:43Z","timestamp":1761415483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950621011161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1443950621011161"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2021.07.001","relation":{},"ISSN":["1443-9506"],"issn-type":[{"type":"print","value":"1443-9506"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Operator and Institutional Requirements for Transcatheter Mitral Valve Therapies in Australia: a CSANZ and ANZSCTS Position Statement","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}